Disease Self ManagementNCT06502574
Self-Care Management in Older Adults
A study testing mobile application in people with Disease Self Management, run by Sultan Ayaz Alkaya at 1 site in Turkey (Türkiye).
Trial summary
Self-management of chronic diseases requires the ability to manage the symptoms, treatment, and lifestyle changes inherent in living with achronic disease. Rational drug use by older adults is of particular importance. Read more about this study
- Who is it for?
- Ages 60 to 79 yearsHealthy volunteers can take part
- Conditions the study is for
- Disease Self Management
- What is being tested?
- mobile application
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 70 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 20 Jul 2024to 30 Mar 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 to 79 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Being in the 60-79 age group,
- Having a chronic disease that requires constant monitoring and treatment
- Using at least one medication for your disease regularly
- Having smart phone usage skills
Who cannot join
- Having vision and hearing problems
- Being 80 or older
- Having a neuro-psychiatric disease
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Strengthening Participation in Social Life Through Rational Drug Use and Disease Self-Care Management inOlder Adults
Self-management of chronic diseases requires the ability to manage the symptoms, treatment, and lifestyle changes inherent in living with achronic disease. Rational drug use by older adults is of particular importance. Mobile applications are being developed to facilitate thecompliance of older adults with chronic diseases with medication treatment and to increase their disease self-management skills. The researchwas planned to strengthen participation in social life through rational drug use and disease self-care management in older adults with chronicdiseases. The research will be conducted in a parallel group randomized controlled manner. In the research, a mobile application will bedeveloped for the use of older adults. Older adults will be asked to use the mobile application for at least 6 months, and the scales will be re-administered face to face or online in the 3rd and 6th months of the intervention.
- Conditions
- Disease Self Management
- Being tested
- mobile application
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
mobile applicationOther
The mobile application prepared for rational drug use andchronic disease self-management, suitable for use by olderadults, will be required to be used for 6 months.
| Study group | Role | What they receive |
|---|---|---|
| mobile application | Experimental | Older adults will be asked to use the mobile application for atleast 6 months, and the scales will be re-administered face toface or online in the 3rd and 6th months of the intervention. Receives: Other: mobile application |
| Control | No intervention | No intervention has been made. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Participation in social life (Social Inclusion Scale)
It was developed in 2009 by Secker et al. to measure an individual's relationship with other people. A validity and reliability study of theTurkish version of the scale was conducted. 4 items were removed from the original 22-item scale and the final version consisted of 18items. The lowest and highest that can be taken from the scale are 18 and 72. A higher score from the scale indicates more socialization.
Measured: Baseline
Participation in social life (Social Inclusion Scale)
It was developed in 2009 by Secker et al. to measure an individual's relationship with other people. A validity and reliability study of theTurkish version of the scale was conducted. 4 items were removed from the original 22-item scale and the final version consisted of 18items. The lowest and highest that can be taken from the scale are 18 and 72. A higher score from the scale indicates more socialization.
Measured: within first week]
Participation in social life (Social Inclusion Scale)
It was developed in 2009 by Secker et al. to measure an individual's relationship with other people. A validity and reliability study of theTurkish version of the scale was conducted. 4 items were removed from the original 22-item scale and the final version consisted of 18items. The lowest and highest that can be taken from the scale are 18 and 72. A higher score from the scale indicates more socialization.
Measured: twelfth week]
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Jul 2024
- Study start20 Jul 2024
- Primary completion25 Dec 2025
- Study completion30 Mar 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Disease Self ManagementStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 70 participants (actual)
Sponsor and investigators
- Lead sponsor
- Sultan Ayaz Alkaya
- Sponsor type
- University, hospital or other
- Collaborators
- Health Institutes of Turkey
- Responsible party
- Sponsor-investigator, Sultan Ayaz Alkaya, Gazi University
- Investigators
- Sultan Ayaz Alkaya, PhD, Principal investigator, Gazi University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06502574
- Sponsor's protocol ID
- 2024-341
- Status last verified
- Jul 2024
- First submitted
- 9 Jul 2024
- Last updated
- 8 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Strengthening Participation in Social Life Through Rational Drug Use and Disease Self-Care Management inOlder Adults
- ClinicalTrials.gov ID
- NCT06502574
- Acronym / sponsor ID
- 2024-341
- Conditions
- Disease Self Management
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 70 participants (actual)
- Lead sponsor
- Sultan Ayaz AlkayaUniversity, hospital or other
- Collaborators
- Health Institutes of Turkey
- Study start
- 20 Jul 2024 (actual)
- Primary completion
- 25 Dec 2025 (actual)
- Study completion
- 30 Mar 2026 (actual)
- First posted
- 16 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Self-management of chronic diseases requires the ability to manage the symptoms, treatment, and lifestyle changes inherent in living with achronic disease. Rational drug use by older adults is of particular importance. Mobile applications are being developed to facilitate thecompliance of older adults with chronic diseases with medication treatment and to increase their disease self-management skills. The researchwas planned to strengthen participation in social life through rational drug use and disease self-care management in older adults with chronicdiseases. The research will be conducted in a parallel group randomized controlled manner. In the research, a mobile application will bedeveloped for the use of older adults. Older adults will be asked to use the mobile application for at least 6 months, and the scales will be re-administered face to face or online in the 3rd and 6th months of the intervention.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| mobile application | Experimental | Other: mobile applicationOlder adults will be asked to use the mobile application for atleast 6 months, and the scales will be re-administered face toface or online in the 3rd and 6th months of the intervention. |
| Control | No intervention | –No intervention has been made. |
Who may qualify
- Ages
- 60 to 79 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Being in the 60-79 age group,
- Having a chronic disease that requires constant monitoring and treatment
- Using at least one medication for your disease regularly
- Having smart phone usage skills
Key exclusion criteria (3 listed)
- Having vision and hearing problems
- Being 80 or older
- Having a neuro-psychiatric disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| mobile applicationThe mobile application prepared for rational drug use andchronic disease self-management, suitable for use by olderadults, will be required to be used for 6 months. | Other | mobile application |
Primary outcome
Participation in social life (Social Inclusion Scale)
Time frame: Baseline
It was developed in 2009 by Secker et al. to measure an individual's relationship with other people. A validity and reliability study of theTurkish version of the scale was conducted. 4 items were removed from the original 22-item scale and the final version consisted of 18items. The lowest and highest that can be taken from the scale are 18 and 72. A higher score from the scale indicates more socialization.
Participation in social life (Social Inclusion Scale)
Time frame: within first week]
It was developed in 2009 by Secker et al. to measure an individual's relationship with other people. A validity and reliability study of theTurkish version of the scale was conducted. 4 items were removed from the original 22-item scale and the final version consisted of 18items. The lowest and highest that can be taken from the scale are 18 and 72. A higher score from the scale indicates more socialization.
Participation in social life (Social Inclusion Scale)
Time frame: twelfth week]
It was developed in 2009 by Secker et al. to measure an individual's relationship with other people. A validity and reliability study of theTurkish version of the scale was conducted. 4 items were removed from the original 22-item scale and the final version consisted of 18items. The lowest and highest that can be taken from the scale are 18 and 72. A higher score from the scale indicates more socialization.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Apr 2026.
Related trials for Disease Self Management
Recruiting
HOBSCOTCH-MS-Efficacy Trial
Multiple Sclerosis, Cognitive Dysfunction
Recruiting
HOBSCOTCH-YOUTH and Young Adults
Epilepsy, Cognitive Dysfunction, Cognitive Disorder
Not yet recruiting
Hybrid mHealth for Low Back Pain
Chronic Low-back Pain (cLBP), Non-specific Low Back Pain (NSLBP)
Active, not recruiting
PREWELL Digital Well-being Promotion Intervention With the BitHabit App
General Mental Health and Well-Being, Mental Disorders
Active, not recruiting
Helping Adults With Type 2 Diabetes Use Their Health Data for Healthy Diabetes Self-Management
Type 2 Diabetes Mellitus (T2DM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sultan Ayaz Alkaya, PhD principal investigator
Gazi University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing mobile application in people with Disease Self Management, run by Sultan Ayaz Alkaya at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Participation in social life (Social Inclusion Scale) (time frame: Baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2026.